Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center for Human Genetics, |
RCV000659457 | SCV000781272 | likely pathogenic | Ehlers-Danlos syndrome, classic type | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV002235655 | SCV000819694 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001766433 | SCV002009029 | uncertain significance | not provided | 2023-04-06 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Occurs in the triple helical domain at the X position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the X position is not a common mechanism of disease (Symoens et al., 2012; HGMD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Mendelics | RCV002249390 | SCV002518139 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001766433 | SCV004225176 | uncertain significance | not provided | 2023-06-27 | criteria provided, single submitter | clinical testing | BS1 |
Genome |
RCV000659457 | SCV002075075 | not provided | Ehlers-Danlos syndrome, classic type | no assertion provided | phenotyping only | Variant interpreted as Uncertain significance and reported on 04-19-2021 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |